XML 40 R28.htm IDEA: XBRL DOCUMENT v3.20.4
Stockholders' Equity (Tables)
6 Months Ended
Dec. 31, 2020
Stockholders' Equity  
Schedule of stock-based compensation expense in the consolidated statements of operations

We recorded stock-based compensation expense in the consolidated statements of operations as follows (in thousands):

    

Three Months Ended December 31, 

    

Six Months Ended December 31, 

2019

    

2020

    

2019

    

2020

Cost of goods sold

$

156

$

194

$

328

$

373

Selling, general and administrative

 

5,548

5,384

 

11,633

 

11,168

Research and development

 

140

135

 

299

 

280

Stock-based compensation expense

$

5,844

$

5,713

$

12,260

$

11,821

Summary of stock option activity

Weighted

Average

Weighted-Average

Aggregate

Number of

Exercise

Remaining Contractual

Intrinsic Value

    

Options

    

Price

    

Term

    

(in thousands)

Outstanding at June 30, 2020

 

326,304

 

$

44.41

 

Granted

 

22,171

82.17

Exercised

 

(77,532)

30.70

Expired or forfeited

 

(2,710)

78.71

Outstanding at December 31, 2020

 

268,233

51.14

3.1 years

$

11,392

Exercisable at December 31, 2020

227,849

44.77

 

2.0 years

11,039

Summary of RSU award activity

Weighted-

Average

    

Shares

    

Fair Value

Nonvested at June 30, 2020

 

423,590

$

88.68

Granted

 

337,778

80.32

Vested

 

(304,420)

85.95

Forfeited

 

(7,150)

85.08

Nonvested at December 31, 2020

 

449,798

$

84.31